Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from EUDA Health Holdings ( (EUDA) ) is now available.
On April 28, 2026, EUDA Health Holdings highlighted that Shenzhen Inno Immune Co., Ltd., a Chinese cellular therapy developer whose immunotherapies EUDA distributes in Malaysia, received official approval under the 2025 Shenzhen Key Industry R&D Program for a TCR‑T cell therapy project targeting solid tumors. The project, which may receive up to about US$434,688 in government funding for work scheduled from January 1, 2026, to December 31, 2028, strengthens EUDA’s exposure to next‑generation T‑cell therapies and supports its strategy to broaden access to advanced, science-driven treatments through its commercial channels in Asia.
Shenzhen Inno’s research will use AI-driven antigen screening, enhanced TCR‑T cell engineering, and clinical collaboration with Shenzhen People’s Hospital to tackle challenges such as tumor heterogeneity, immune resistance, and T‑cell exhaustion. By aligning with this government-backed initiative and leveraging its existing non-exclusive distribution arrangement, EUDA positions itself to benefit from progress in cutting-edge cellular immunotherapies, potentially reinforcing its role in the regional shift from reactive treatment toward proactive, longevity-focused care.
The most recent analyst rating on (EUDA) stock is a Buy with a $2.75 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based non-invasive healthcare provider focused on Singapore, Malaysia and China, aiming to lead in preventive and longevity-focused care across a rapidly aging regional population of over 1.8 billion people. The company offers innovative, accessible, science-backed health solutions and also operates a Singapore-based property management business.
Average Trading Volume: 96,076
Technical Sentiment Signal: Sell
Current Market Cap: $26.71M
For an in-depth examination of EUDA stock, go to TipRanks’ Overview page.